IL15 and glioblastoma: Ma et al. generated an IL-15/IL15 receptor alpha (IL-15Rα) fusion OV (OV-IL15C) for combinatorial therapy with EGFR-CAR NK-cells for the treatment of GBM [66] (Table 2).